Cite
HARVARD Citation
Kim, S. et al. (2022). Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07. Journal of clinical oncology. 40 (33), pp. 3868-3877. [Online].